Australian retail investors were able to apply for Medibank Private shares from Tuesday, 28 October 2014.

The indicative price range for Medibank Private shares has been set at $1.55 to $2.00 per share.

A price cap for retail investors means that Australian residents who choose to apply for shares will not pay any more than $2.00 per share, even if the final price is set above the indicative range.

At the indicative price range, the indicative market capitalisation of Medibank Private would be $4,269 – $5,508 million, which would place it among the top 100 companies on the ASX.

The Government intends to sell down its entire shareholding.

The launch of the offer follows a successful pre-registration process where more than 750,000 Australians pre-registered to receive the Medibank Private Share Offer prospectus. There was strong support from Medibank and ahm policy holders.

Australian residents who pre-registered their interest in receiving a prospectus and apply for shares in the General Public Offer can be allocated an amount of shares up to 15 per cent higher than General Public Offer applicants who did not pre-register.

Eligible Medibank Private and ahm policyholders who pre-registered and apply for shares in the Policyholder Offer can be allocated an amount of shares up to 30 per cent higher than General Public Offer applicants who did not pre-register.

Eligible4 Medibank Private and ahm policyholders who did not pre-register are still eligible to apply for shares in the Policyholder Offer and can still be allocated an amount of shares up to 15 per cent higher than General Public Offer applicants who did not pre-register.

Potential investors who have not pre-registered can get a prospectus by calling 1800 998 778 or visiting medibankprivateshareoffer.com.au.
The Government has long been committed to the sale of Medibank Private.